Related references
Note: Only part of the references are listed.Neurofilament dynamics and involvement in neurological disorders
Benoit J. Gentil et al.
CELL AND TISSUE RESEARCH (2015)
Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
M. Alba Mane Martinez et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Neurofilament light chain A prognostic biomarker in amyotrophic lateral sclerosis
Ching-Hua Lu et al.
NEUROLOGY (2015)
Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
Jens Kuhle et al.
NEUROLOGY (2015)
Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy
Yulia Surova et al.
NEURORADIOLOGY (2015)
Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
M. Alba Mane Martinez et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis
L. M. Villar et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Cerebrospinal Fluid Neurofilament Concentration Reflects Disease Severity in Frontotemporal Degeneration
Carole S. Scherling et al.
ANNALS OF NEUROLOGY (2014)
CSF neurofilament light chain is elevated in OMS (decreasing with immunotherapy) and other pediatric neuroinflammatory disorders
Michael R. Pranzatelli et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
Combination fluconazole/paroxetine treatment is neuroprotective despite ongoing neuroinflammation and viral replication in an SIV model of HIV neurological disease
Kelly A. Meulendyke et al.
JOURNAL OF NEUROVIROLOGY (2014)
Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial
Adam L. Boxer et al.
LANCET NEUROLOGY (2014)
The Phenotypic Spectrum of Progressive Supranuclear Palsy: A Retrospective Multicenter Study of 100 Definite Cases
Gesine Respondek et al.
MOVEMENT DISORDERS (2014)
Neurological Assessment and Its Relationship to CSF Biomarkers in Amateur Boxers
Sanna Neselius et al.
PLOS ONE (2014)
Progressive Supranuclear Palsy
Lawrence I. Golbe
SEMINARS IN NEUROLOGY (2014)
Clinical Trials: Past, Current, and Future for Atypical Parkinsonian Syndromes
Richard M. Tsai et al.
SEMINARS IN NEUROLOGY (2014)
Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases
Johanna Gaiottino et al.
PLOS ONE (2013)
Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
Sara Hall et al.
ARCHIVES OF NEUROLOGY (2012)
Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations
David M. Rissin et al.
NATURE BIOTECHNOLOGY (2010)
Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores
Sid E. O'Bryant et al.
ARCHIVES OF NEUROLOGY (2008)
A clinical rating scale for progressive supranuclear palsy
Lawrence I. Golbe et al.
BRAIN (2007)
Prevalence of progressive supranuclear palsy in Yonago, Japan
M Kawashima et al.
MOVEMENT DISORDERS (2004)
The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK
U Nath et al.
BRAIN (2001)
Share Paper
